Assess target-controlled infusion system accuracy by measuring whole blood propofol concentrations

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800014501

Enrollment

Unknown

Registered

2018-01-17

Start date

2018-02-01

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal surgery, thoracic surgery, ERCP

Interventions

Case series:Propofol by intravenous anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aged 18-70 years old, elective surgery,Anesthesia is well tolerated

Exclusion criteria

Exclusion criteria: Body mass index (BMI)> 35, liver and kidney dysfunction, propofol allergy, ASA grade 4

Design outcomes

Primary

Measure	Time frame
propofol plasma concentration;	—

Countries

China

Contacts

Public ContactDesheng Liu

The First Affiliated Hospital of Harbin Medical University

liudeshengmz@sina.com+86 15846581162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026